Papp L Roy & Associates Amgen Inc Transaction History

Papp L Roy & Associates

$820 Million
Q3 2024

A detailed history of Papp L Roy & Associates transactions in Amgen Inc stock. As of the latest transaction made, Papp L Roy & Associates holds 6,458 shares of AMGN stock, worth $1.71 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

6,458

Previous 6,458 -0.0%

Holding current value

$1.71 Million

Previous $2.02 Million 3.12%

% of portfolio

0.25%

Previous 0.25%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	BUY	$262.75 - $319.31 $262 - $319	1 Added 0.02%	6,458 $2.02 Million
Q1 2024 Apr 15, 2024	BUY	$268.87 - $324.56 $64,797 - $78,218	241 Added 3.88%	6,457 $1.84 Million
Q3 2023 Oct 18, 2023	SELL	$218.65 - $271.46 $143,215 - $177,806	-655 Reduced 9.53%	6,216 $1.67 Million
Q4 2022 Jan 17, 2023	SELL	$229.03 - $291.01 $189,178 - $240,374	-826 Reduced 10.73%	6,871 $0
Q3 2022 Oct 21, 2022	SELL	$224.46 - $253.15 $13,467 - $15,189	-60 Reduced 0.77%	7,697 $1.74 Million
Q2 2022 Aug 02, 2022	BUY	$230.71 - $256.74 $13,611 - $15,147	59 Added 0.77%	7,757 $1.89 Million
Q1 2022 May 06, 2022	SELL	$219.27 - $242.57 $140,332 - $155,244	-640 Reduced 7.68%	7,698 $1.86 Million
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $186,947 - $213,944	-940 Reduced 10.13%	8,338 $1.88 Million
Q3 2021 Nov 09, 2021	SELL	$212.27 - $248.7 $148,589 - $174,090	-700 Reduced 7.02%	9,278 $1.97 Million
Q2 2021 Aug 09, 2021	BUY	$233.58 - $259.14 $231,711 - $257,066	992 Added 11.04%	9,978 $2.43 Million
Q1 2021 May 06, 2021	SELL	$221.91 - $258.6 $445,595 - $519,268	-2,008 Reduced 18.26%	8,986 $2.24 Million
Q4 2020 Feb 10, 2021	SELL	$216.38 - $257.67 $264,199 - $314,615	-1,221 Reduced 10.0%	10,994 $2.53 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $23,465 - $26,095	100 Added 0.83%	12,215 $3.11 Million
Q2 2020 Aug 11, 2020	SELL	$197.81 - $242.74 $13,451 - $16,506	-68 Reduced 0.56%	12,115 $2.86 Million
Q1 2020 May 05, 2020	SELL	$182.24 - $241.7 $38,817 - $51,482	-213 Reduced 1.72%	12,183 $2.47 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $2,459 - $3,161	13 Added 0.1%	12,396 $2.99 Million
Q3 2019 Nov 04, 2019	SELL	$174.11 - $208.62 $27,335 - $32,753	-157 Reduced 1.25%	12,383 $2.4 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $88,351 - $103,567	530 Added 4.41%	12,540 $2.31 Million
Q1 2019 May 09, 2019	SELL	$180.87 - $203.88 $100,563 - $113,357	-556 Reduced 4.42%	12,010 $2.28 Million
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $79,744 - $93,087	447 Added 3.69%	12,566 $2.45 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $18,529 - $20,889	-100 Reduced 0.82%	12,119 $2.51 Million
Q2 2018 Aug 09, 2018	SELL	$166.05 - $186.51 $208,392 - $234,070	-1,255 Reduced 9.31%	12,219 $2.26 Million
Q1 2018 May 15, 2018	BUY	$169.43 - $198.0 $724,143 - $846,252	4,274 Added 46.46%	13,474 $2.3 Million
Q4 2017 Feb 06, 2018	BUY	$168.79 - $188.59 $70,891 - $79,207	420 Added 4.78%	9,200 $1.6 Million
Q3 2017 Nov 06, 2017	BUY	$167.29 - $191.0 $1.47 Million - $1.68 Million	8,780	8,780 $1.64 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Papp L Roy & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Papp L Roy & Associates with notifications on news.

Account

Papp L Roy & Associates Amgen Inc Transaction History